Tag: Coronavirus Vaccine

Anti-viral-Drug
Glenmark to start trial combining 2 anti-viral drugs on Covid patients in India

New Delhi: Glenmark Pharmaceuticals announced on Tuesday that it will commence another new Phase 3 clinical trial on a combination of two anti-viral drugs Favipiravir and Umifenovir in hospitalized patients of moderate COVID-19 in India. Glenmark has received approval from the Indian regulator to initiate the study. The combination study which will be called the […]

  • Friday, 16 April 2021
GSk--GlaxoSmithKline
GSK To Produce One Billion Doses Of Covid-19 Vaccine Booster Next Year

London: Pharmaceutical giant GlaxoSmithKline on Thursday said it plans to produce 1 billion doses of coronavirus vaccine adjuvant, an ingredient that makes vaccines work better, in 2021 to support multiple Covid-19 vaccine collaborations. Saying that it has started manufacture of the adjuvant at risk, the company added that it was in discussions with governments and […]

  • Friday, 16 April 2021
COVID-19-vaccine
Covid-19 vaccine: Pfizer CEO claims medicine could be ready by October

New York: Global pharmaceutical major Pfizer believes that a Covid-19 vaccine could be ready by the end of October, the company’s CEO Albert Bourla said. Pfizer is conducting clinical trials in the US and Europe for the BNT162 vaccine programme to prevent Covid-19 in collaboration with German mRNA company BioNTech. Bourla made the comments while […]

  • Friday, 16 April 2021
Coronavirus-Vaccine
COVID-19 Vaccine Likely In 2020, But Production Only By 2021 End

New Delhi: Swedens chief epidemiologist Dr Anders Tegnell said Covid-19 vaccine may be developed in 2020, but its production will only start by the end of 2021. In a webinar organized by Public Health Foundation of India, Tegnell, who is also the architect of Covid-19 Sweden’s lockdown-lite, said: “To reach full herd immunity to stop […]

  • Friday, 16 April 2021
COVID-19-vaccine
Johnson & Johnson To Begin Human Trial Of Covid Vaccine In July

New York: Johnson & Johnson on Wednesday said that it has accelerated the first in-human clinical trial of its investigational SARS-CoV-2 vaccine in the second half of July via its Janssen Pharmaceutical Companies (Janssen). The trial for the vaccine, Ad26.COV2-S, recombinant, was initially scheduled to begin in September. “Based on the strength of the preclinical […]

  • Friday, 16 April 2021
covaxin
COVID-19 Vaccine: India Sounds Confident Of Covaxin

New Delhi: As India races to bring a vaccine for Covid-19 by mid-August, the government on Sunday said that it is entering the human trial stage which “marks the beginning of the end”. COVAXIN by Bharat Biotech and ZyCov-D vaccine by Zydus Cadila is India’s own efforts to bring a vaccine for this global pandemic. […]

  • Thursday, 15 April 2021
COVID19-Vaccine
COVID-19 Vaccine: Russia Plans Mass Vaccination From October

Moscow: Russia is planning a mass vaccination campaign against the novel coronavirus from October, Health Minister Mikhail Murashko said. “We plan wider (vaccination) from October because we need to launch a new system of treatment gradually,” the Minister told TASS News Agency on Saturday. Murashko pointed out earlier that clinical trials of a coronavirus vaccine […]

  • Wednesday, 14 April 2021
Covid-19-vaccine
India To Have Coronavirus Vaccine By 2020 End: Union Health Minister Harsh Vardhan

New Delhi: Union Minister of Health and Family Welfare Harsh Vardhan said on Saturday that the country will have a vaccine against the deadly coronavirus by the end of the year. Speaking to reporters here, he said that a Covid-19 vaccine is likely in the next 4-5 months. “I hope that if everything goes well, […]

  • Tuesday, 13 April 2021
Sputnik-V
Russian Vaccine 'Sputnik V' Found Safe In Early Human Trials

London: A Russian Covid-19 vaccine has shown no serious side effects and elicited an immune response in early human trials, said a study published in The Lancet on Friday. Russia last month registered the “Sputnik V”, becoming the first country to approve a Covid-19 vaccine. However, the country faced criticism for approving a vaccine before […]

  • Monday, 12 April 2021
COVID19-Vaccine
Oxford Covid Vaccine Trials Delayed Over Safety Approvals

New Delhi: The clinical trials for the Covid-19 vaccine candidate developed by the University of Oxford, which was expected to start at The Post Graduate Institute of Medical Education and Research (PGIMER) in Chandigarh, have been delayed by at least a week. The trials that were expected to commence in the first week of September […]

  • Monday, 12 April 2021
Sputnik-V-vaccine
Covid-19: Russia Produces First Batch Of Sputnik V Vaccine For Civilian Circulation

Moscow/New Delhi: In some good news for millions living in hope for a Covid-19 vaccine shot, the Russian Health Ministry said on Tuesday that the first batch of Sputnik V vaccine has been produced for civilian circulation. The supplies of the medication to the Russian regions are expected soon, the Health Ministry told reporters, reports […]

  • Monday, 12 April 2021
Anti-Fibrotic Drugs
Now, Pre-Book Your Vaccination Through App

New Delhi: A Mumbai-based health-tech start-up has launched an application for Indian citizens to book an appointment with the nearest doctor or the vaccination clinic to get themselves vaccinated. This comes at a time when the country is waiting for the coronavirus vaccine with bated breath. WONDRx is a made-in-India health-tech start-up working on Digital India […]

  • Monday, 12 April 2021
Corona Vaccine
BJP's Free Covid-19 Vaccine Promise In Bihar Poll Manifesto Creates Stir In Odisha Politics

Bhubaneswar: A day after the BJP announced free Covid-19 vaccination for all in Bihar as part of its election manifesto; the announcement has heated up politics in Odisha. Ruling-BJD legislator Arabinda Dhali reacted sharply at BJP’s announcement and said it is ‘appalling’ that a vaccine to fight the pandemic is being made a poll agenda. […]

  • Saturday, 10 April 2021
Pfizer
Pfizer COVID19 Vaccine 95% Effective, Seeks Emergency Clearance

New York: Pfizer and its German partner BioNTech released a second batch of interim results on Wednesday, saying their coronavirus vaccine candidate is 95 per cent effective and also protects the most vulnerable people in older age groups from the risk of falling prey to the virus. “Primary efficacy analysis demonstrates BNT162b2 to be 95 […]

  • Friday, 09 April 2021
Covid Vaccine
Covid-19: Odisha Plans Vaccination Drive On Lines Of Poll Process

Bhubaneswar: With nation-wide anticipation building up over launching of Covid-19 vaccine possibly in the next few weeks, the Odisha Government has firmed up its blueprint for the mass vaccination that is expected to roll out with the onset of New Year. According to sources, the State government has planned to undertake the vaccination drive on […]

  • Monday, 01 March 2021
scrollToTop